PMID: 6800533Feb 20, 1982

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist

British Medical Journal
G J WentingM A Schalekamp


The new selective 5-HT2 receptor blocking agent ketanserin was given in a dose of 10 mg intravenously to 12 patients with essential hypertension. It caused a distinct fall in supine systemic arterial, right atrial, pulmonary artery, and pulmonary capillary "wedge" pressures. Cardiac output, renal blood flow, and glomerular filtration rate showed no persistent changes. Thus 5-HT2 receptor blockade caused dilatation of both resistance and capacitance vessels and of the renal vascular bed. Heart rate and plasma concentrations of renin and noradrenaline rose after ketanserin. These data suggest that 5-HT may have a role in maintaining high blood pressure.


Jun 1, 1995·Journal of Clinical Pharmacology·W H FrishmanB Shareef
Jan 1, 1985·European Journal of Clinical Pharmacology·I W ReimannU Klotz
Jan 1, 1983·European Journal of Clinical Pharmacology·I W ReimannU Klotz
Jan 1, 1985·European Journal of Clinical Pharmacology·M Kurowski
Jan 1, 1987·European Journal of Clinical Pharmacology·B PerssonT Hedner
Jan 1, 1987·European Journal of Clinical Pharmacology·A BerdeauxJ F Giudicelli
Jan 1, 1983·European Journal of Clinical Pharmacology·B PerssonG Berglund
Jan 1, 1991·Acta neurochirurgica·J F SchmidtO B Paulson
Jul 31, 1985·European Journal of Pharmacology·A G Ramage
Jan 13, 1987·European Journal of Pharmacology·J NishimuraM Nakamura
Sep 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·T J SchneiderH C Wallenburg
Mar 13, 2012·Pharmacological Reviews·Stephanie W WattsSusan M Barman
Oct 16, 1982·British Medical Journal·E StrandenK Krohg
Apr 1, 1987·Postgraduate Medical Journal·P C WallerL E Ramsay
Oct 1, 1983·Journal of the Autonomic Nervous System·H Ahlman, A Dahlström
Jan 1, 1988·European Journal of Clinical Pharmacology·C BartoloniF Kaindl
Jan 1, 1990·Cardiovascular Drugs and Therapy·M KonishiN Tsushima
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·J MileiE Bernardiner
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·T HednerG Berglund
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·L M WingJ R Graham
May 23, 2000·Annals of Medicine·W H Frishman, P Grewall
Jun 25, 2008·Neuroscience and Biobehavioral Reviews·Eugene Nalivaiko, Andrea Sgoifo
May 4, 2010·Cardiovascular Therapeutics·Stephanie W Watts, Robert Patrick Davis
Aug 1, 1983·British Journal of Clinical Pharmacology·T HednerG Berglund
Sep 1, 1986·British Journal of Pharmacology·S ConolanD A Taylor
Jul 1, 1987·British Journal of Clinical Pharmacology·P C WallerL E Ramsay
Nov 1, 1988·Journal of Clinical Pharmacology·T KosoglouR K Ferguson
Mar 1, 1984·British Journal of Clinical Pharmacology·J M WalkerD J Coltart
Nov 1, 1986·The American Journal of the Medical Sciences·J E Millen, F L Glauser
Jul 1, 1985·Clinical Allergy·S Y SoS Kwan
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S A CummingsR J Groszmann
Mar 1, 1984·Clinical and Experimental Pharmacology & Physiology·J F Marwood, G S Stokes
Sep 1, 1984·Clinical and Experimental Pharmacology & Physiology·J F Marwood, G S Stokes
Nov 1, 1984·Clinical and Experimental Pharmacology & Physiology·M A NelsonB A Scoggins


Sep 4, 1976·Lancet·F H DerkxM A Schalekamp
Oct 1, 1979·Annals of Surgery·H L Pachter, F C Spencer
Feb 1, 1975·Life Sciences·D P HenryR H Williams
Jan 1, 1970·Clinical Science·M A SchalekampW Birkenhäger
May 23, 1981·Lancet·J De CreeJ Symoens
Aug 1, 1980·The Journal of Clinical Investigation·P D Henry, M Yokoyama

Related Concepts

Antagonist Muscle Action
Receptors, Tryptamine
Pathological Dilatation
Essential Hypertension
Norepinephrine, (+, -)-Isomer
Pulmonary Artery Structure

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.